Alx Oncology Holdings (ALXO) — Cash Flow-to-Debt Ratio
Alx Oncology Holdings (ALXO) has a Cash Flow-to-Debt Ratio of -0.45x as of September 2025, meaning its operating cash flow of $-17.09 Million could theoretically repay 0% of its total liabilities ($37.92 Million) in one year. See ALXO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alx Oncology Holdings Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Alx Oncology Holdings across 7 annual periods. Also explore Alx Oncology Holdings (ALXO) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Alx Oncology Holdings (2018–2024)
Year-by-year debt coverage analysis for Alx Oncology Holdings . For market capitalisation and broader financial context, see Alx Oncology Holdings (ALXO) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.57x | $-121.91 Million | $34.16 Million | ▼ -44.7% |
| 2023 | -2.47x | $-130.36 Million | $52.84 Million | ▼ -19.0% |
| 2022 | -2.07x | $-89.22 Million | $43.02 Million | ▲ +47.8% |
| 2021 | -3.97x | $-68.10 Million | $17.13 Million | ▲ +35.5% |
| 2020 | -6.17x | $-38.29 Million | $6.21 Million | ▼ -374.0% |
| 2019 | -1.30x | $-14.25 Million | $10.95 Million | ▲ +80.2% |
| 2018 | -6.57x | $-13.19 Million | $2.01 Million | — |